ITGAX and neoplasm: CHRNA7KO mice had decreased levels of MHCII, CD11c, and CD83 expression in CD11b+ cell subsets (Fig. 4B–D), while no overall changes in the numbers of CD11b+ or F4/80+ tumor macrophages were observed (Fig. 4E, F).